| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.05 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.05 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |